The effect of healthcare disruptions during the COVID ‐19 pandemic on colposcopy services and practice: A systematic review and meta‐analysis
Acta Obstetricia et Gynecologica Scandinavica · 2025
DOI: 10.1111/aogs.70066 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2025. Verfasst von Giovanni Delli Carpini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica Delle Marche, Ancona, Italy. Hauptthemen laut MEDLINE: COVID-19, Colposcopy, Uterine Cervical Neoplasms, Delivery of Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction The healthcare reorganization during the COVID‐19 pandemic affected colposcopy services and cervical cancer prevention, particularly in those countries where healthcare systems were already under‐resourced. This review aimed to quantify the reduction in colposcopy services across countries during the COVID‐19 pandemic and to determine whether the data source per study and cervical cancer screening coverage per country influenced the extent of these reductions. Material and Methods Studies reporting comparative data on colposcopy services between the COVID‐19 pre‐pandemic and pandemic period were included. MEDLINE, Embase, EMCare, Covid‐19 Research, British Nursing Index, APA PsycINFO, and Allied and Complimentary Medicine databases were searched for studies published from March 2020 to December 2023. The Newcastle−Ottawa scale was used for risk of bias assessment. The number of colposcopies, cervical treatments, pre‐invasive lesions diagnoses, and cervical cancer diagnoses per month were compared between the pre‐pandemic (before March 2020) and pandemic period (after March 2020). The effect measure was the standardized mean difference. Heterogeneity was evaluated with the chi‐squared test and quantified with the I 2 method. A meta‐regression was performed, considering the data source (regional/national databases/registries or institutional databases) and the screening coverage according to World Health Organization data (≥70% or
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica Delle Marche, Ancona, Italy.
- Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
- European Federation for Colposcopy, Triumph Benelux, Brussels, Belgium.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Obstetrics and Gynecology, Gødstrup Hospital, University Clinic for HPV-Related Gynecological Disease, Herning, Denmark.
- Department Obstetrics and Gynecology, University of Medicine and Pharmacy "Grigore T. Popa", Iasi, Romania.
ORCID-Profile: Anne Hammer
Zitieren
APA
Delli Carpini, G., Mammadov, Z., Leeson, S., Hammer, A., Grigore, M., & Ciavattini, A. (2025). The effect of healthcare disruptions during the COVID ‐19 pandemic on colposcopy services and practice: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70066
Vancouver
Delli Carpini G, Mammadov Z, Leeson S, Hammer A, Grigore M, Ciavattini A. The effect of healthcare disruptions during the COVID ‐19 pandemic on colposcopy services and practice: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70066
BibTeX
@article{DelliCarpini2025,
author = {Delli Carpini, Giovanni and Mammadov, Zahid and Leeson, Simon and Hammer, Anne and Grigore, Mihaela and Ciavattini, Andrea},
title = {The effect of healthcare disruptions during the COVID ‐19 pandemic on colposcopy services and practice: A systematic review and meta‐analysis},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2025},
doi = {10.1111/aogs.70066}
}
EUVIMED